You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart

Article: P.12 Evaluation of CD200 expression in differential diagnosis of CD5+ B cell NHLs

€3.03

SKU: product-article-21187 Category: General

Description
Reviews (0)

Description

P.12 Evaluation of CD200 expression in differential diagnosis of CD5+ B cell NHLs

Reviews

There are no reviews yet.

Be the first to review “Article: P.12 Evaluation of CD200 expression in differential diagnosis of CD5+ B cell NHLs”

You must be logged in to post a review.

Top

Article: P.12 Evaluation of CD200 expression in differential diagnosis of CD5+ B cell NHLs

Description

Reviews

Related products

Article: INTRODUCTION

Article: Highlights in digestive oncology

Article: Highlights in melanoma

Article: Highlights in respiratory oncology